Folate supplementation in methotrexate-treated rheumatoid arthritis patients

Weinblatt, 1985, Efficacy of low dose methotrexate in rheumatoid arthritis, N Engl J Med, 312, 818, 10.1056/NEJM198503283121303 Williams, 1985, Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: A controlled clinical trial, Arthritis Rheum, 28, 721, 10.1002/art.1780280702 Weinblatt, 1988, Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis, Arthritis Rheum, 31, 167, 10.1002/art.1780310203 Kremer, 1988, A long-term prospective study of the use of methotrexate in rheumatoid arthritis: Update after a mean of fifty-three months, Arthritis Rheum, 31, 577, 10.1002/art.1780310501 Weinblatt, 1985, Toxicity of low-dose methotrexate in rheumatoid arthritis, J Rheumatol, 12, S35 MacKinnon, 1985, Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis, 15, 119 Hendel, 1985, Impact of methotrexate therapy on the folate status of psoriatic patients, Clin Exp Dermatol, 10, 30, 10.1111/j.1365-2230.1985.tb02548.x Dodd, 1985, Megaloblastic anemia in psoriatic patients treated with methotrexate, Br J Dermatol, 112, 630, 10.1111/j.1365-2133.1985.tb15279.x Fulton, 1986, Megaloblastic anaemia and methotrexate treatment, Br J Dermatol, 114, 267, 10.1111/j.1365-2133.1986.tb02812.x Oxholm, 1986, Megaloblastic anaemia and methotrexate treatment, Br J Dermatol, 114, 268, 10.1111/j.1365-2133.1986.tb02813.x Borrie, 1966, Megaloblastic anaemia during methotrexate treatment of psoriasis, Br Med J, 1, 1339, 10.1136/bmj.1.5499.1339 Morgan, 1987, Folate status of rheumatoid arthritis patients receiving long-term lowdose methotrexate therapy, Arthritis Rheum, 30, 1348, 10.1002/art.1780301205 Groff, 1987, Hematologic abnormalities during low dose methotrexate therapy for rheumatoid arthritis, Arthritis Rheum, 30, S41 Weinblatt, 1989, Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy, Arthritis Rheum, 32, 1592, 10.1002/anr.1780321214 Morgan, 1990, The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis, Arthritis Rheum, 33, 9, 10.1002/art.1780330102 Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31, 315, 10.1002/art.1780310302 McGuire, 1980, Enzymatic synthesis of folylpolyglutamates: characterization of the reaction and its products, J Biol Chem, 255, 5776, 10.1016/S0021-9258(19)70697-8 Werkheiser, 1963, The biochemical, cellular, and pharmacological action and effects of the folic acid antagonists, Cancer Res, 23, 1277 White, 1981, Methotrexate resistance in an 1.1210 cell line resulting from increased dihydrofolate reductase, decreased thymidylate synthetase activity, and normal membrane transport: Computer simulations based on network thermodynomics, J Biol Chem, 256, 5722, 10.1016/S0021-9258(19)69266-5 Moran, 1979, Role of thymidylate synthetase activity in development of methotrexate cytotoxicity, 76, 5924 Jolivet, 1983, The pharmacology and clinical use of methotrexate, N Engl J Med, 309, 1094, 10.1056/NEJM198311033091805 Jolivet, 1982, Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells, J Clin Invest, 70, 351, 10.1172/JCI110624 Fry, 1982, Rapid formation of polyglutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro, J Biol Chem, 257, 1890, 10.1016/S0021-9258(19)68121-4 Jolivet, 1983, Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells: Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamates to dihydrofolate reductase, J Clin Invest, 72, 773, 10.1172/JCI111048 Balinska, 1981, Efflux of methotrexate and its polyglutamates derivatives from hepatic cells in vitro, Cancer Res, 41, 2751 Bleyer, 1978, The clinical pharmacology of methotrexate: New applications of an old drug, Cancer, 41, 36, 10.1002/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO;2-I Wilke, 1987, Methotrexate in the treatment of arthritis and connective tissue diseases, Cleve Clin J Med, 54, 327, 10.3949/ccjm.54.4.327 Nesher, 1990, Effects of methotrexate on immunoglobulin production in vitro: Modulation by polyamines and methyl-donors, Arthritis Rheum, 33, R29 Bahremand, 1990, Effects of methotrexate (MTX) on neutrophil (PMN) enzyme release, Arthritis Rheum, 33, R13 Miller, 1986, Methotrexate inhibits interleukin-1 activity, Arthritis Rheum, 29, S86 Olsen, 1987, Immunologie studies of rheumatoid arthritis patients treated with methotrexate, Arthritis Rheum, 30, 481, 10.1002/art.1780300501 Hurd, 1973, Immunosuppressive and anti-inflammatory properties of cyclophosphamide, azathioprine and methotrexate, Arthritis Rheum, 16, 84, 10.1002/art.1780160114 Calabrese, 1990, Response of immunoregulatory lymphocyte subsets to methotrexate in rheumatoid arthritis, Cleve Clin J Med, 57, 232, 10.3949/ccjm.57.3.232 Kamen, 1981, Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug, Br J Haematol, 49, 355, 10.1111/j.1365-2141.1981.tb07237.x Kremer, 1986, Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: Association with hepatic folate deficiency and formation of polyglutamates, Arthritis Rheum, 29, 832, 10.1002/art.1780290703 Mackenzie, 1985, Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis, Cleve Clin Q, 52, 129, 10.3949/ccjm.52.2.129 Mackenzie, 1986, Liver biopsy findings after prolonged methotrexate therapy for rheumatoid arthritis, Rheumatology, 9, 213 Baer, 1986, Accumulation during methotrexate therapy for rheumatoid and psoriatic arthritis, Arthritis Rheum, 29, S41 Polk, 1988, Beneficial effects of leucovorin after methotrexate treatment in rheumatoid arthritis: A case report, Arthritis Rheum, 31, 1587, 10.1002/art.1780311223 Tishler, 1988, The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients, Arthritis Rheum, 31, 906, 10.1002/art.1780310712 Shiroky, 1990, Leucovorin for methotrexate induced elevations in liver transaminases, Arthritis Rheum, 33, R34 Mackenzie, 1971, Management of rheumatoid arthritis in the surgical patient, Ortho Clin North Am, 2, 277, 10.1016/S0030-5898(20)31154-8 Osborn, 1958, Inhibition of dihydrofolate reductase by aminopterin and amethopterin, 97, 429 Segal, 1989, Toxicity of low-dose methotrexate in rheumatoid arthritis